Jayne B. Hart - Sep 17, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief People Officer
Signature
By: Nathan A. Smith For: Jayne B. Hart
Stock symbol
MYGN
Transactions as of
Sep 17, 2021
Transactions value $
-$234,549
Form type
4
Date filed
9/21/2021, 06:18 PM
Previous filing
Aug 26, 2021
Next filing
Sep 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $1.94M +73.2K +91.46% $26.49 153K Sep 17, 2021 Direct
transaction MYGN Common Stock Sale -$2.17M -64.5K -42.06% $33.72 88.8K Sep 17, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $100K +3.78K +4.25% $26.49 92.6K Sep 17, 2021 Direct
transaction MYGN Common Stock Sale -$100K -2.97K -3.2% $33.72 89.6K Sep 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Incentive Stock Option (right to buy) Options Exercise $0 -3.78K -100% $0.00* 0 Sep 17, 2021 Common Stock 3.78K $26.49 Direct F3
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -73.2K -100% $0.00* 0 Sep 17, 2021 Common Stock 73.2K $26.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
F2 Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
F3 The shares subject to this option are fully vested and exercisable.